Tag - DiaSorin

DiaSorin To Acquire Focus Diagnostics’ Molecular And Immunoassay Product Business From Quest Diagnostics

March 31, 2016

👁 1421 views

DiaSorin S.p.A. (F TSE Italy: DIA) and Quest Diagnostics (NYSE: DGX) today announced that they have entered into a purchase agreement under which DiaSorin will...

Tag - DiaSorin

DiaSorin To Acquire Focus Diagnostics’ Molecular And Immunoassay Product Business From Quest Diagnostics

Press Releases

HIE market to hit $3.40B by 2031 (MarketsandMarkets).

NeoGenomics Integrates Cancer Testing with Epic EHR

Timeless Medical Systems® appoints Mike Antonelli as VP of Technology to drive next-generation platform innovation

Luma acquires Tonic to support 1,000+ health systems and 100M patients

Newsletter

Research Papers

Mount Sinai Health System to Deploy Microsoft Dragon Copilot

Ambient AI saves time, eases burnout, and strengthens patient connections

Reactions to EHR-Based Clinical Study Invitations

IDC MarketScape evaluates U.S. EHR vendors